Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy
循环白细胞介素 8 和骨桥蛋白是接受靶向治疗的晚期黑色素瘤患者临床结果的有希望的生物标志物
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-024-03151-3
Lauretta Levati #, Claudio Tabolacci #, Antonio Facchiano, Francesco Facchiano, Ester Alvino, Gian Carlo Antonini Cappellini, Enrico Scala, Laura Bonmassar, Simona Caporali, Pedro Miguel Lacal, Antonella Bresin, Federica De Galitiis, Giandomenico Russo, Stefania D'Atri